ArticleCytotechnology2020
NOL6, a new founding oncogene in human prostate cancer and targeted by miR-590-3p.
Degang Dong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it
ArticleCytotechnology2020
Degang Dong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.